CClinicalTrials.gg
CompletedNCT06062459Updated Oct 2, 2023

Synergistic Benefits of MCE and BT in Sacroiliac Joint Dysfunction: A Randomized Controlled Trial

An interventional study of Motor Control Exercise and Balance Training in Sacroiliac Joint Dysfunction, sponsored by Najran University. Completed at 2 sites in 2 countries. Open to participants aged 30 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-10-02.

Sponsored by Najran University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Nov 2022, registered Sep 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
30 Years to 60 Years
Sex
All
01

Study summary

This research aimed to ascertain the combined and individual efficacies of MCE and BT in alleviating SIJD symptoms.

Read the detailed description

The study will be based on a four-arm parallel group randomized control design. one hundred and twenty participants with SIJD will be recruited from the Physiotherapy department, at Integral University, India. Study objectives and procedure will be properly explained and written informed consent will be obtained at the beginning of the study. All the participants will be randomly divided into four groups A, B, C, and D. Experimental group A will be receiving the hot pack, Stretching exercise, and MCE intervention, group B will receive the hot pack, Stretching exercise, and BT exercise and Group C will be receiving the hot pack, Stretching exercise, and MCE \& BT intervention, control group D will receive the hot pack, Stretching exercise intervention.

02

Conditions studied

  • Sacroiliac Joint Dysfunction

Browse trials for

03

In context

Joint Diseases

712 studies on the registry are indexed under Joint Diseases; 127 are open to participants now.

This study's enrollment of 120 is above the median of 60 across 470 interventional studies indexed under Joint Diseases.

Browse Joint Diseases studies →

Lead sponsor

Najran University is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age-30-60 Years
  • sacroiliac joint pain (>3 months)
  • Presence of pain exacerbated as a result of bending laterally or backward
  • Positive results on at least 2 of the pain-provocation tests [FABER, Posterior shear and Gaenslen pain provocation tests) and one of the motion palpation tests (ie, Gillet and forward flexion tests)

Exclusion criteria

Exclusion Criteria:

  • past or current history of surgery or major trauma to spine, pelvis, lower limb, chest or abdomen in the past 12 months
  • lower extremity musculoskeletal disorders; known localized spinal pathology
  • known congenital anomalies of hip, pelvis or spine that limits mobility
  • known systematic arthropathy, neuropathy or metabolic disorder
  • Presence of other causes of LBP such as lumbar discopathy and spinal stenosis discovered via clinical examination and MRI scanning
  • pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Group A

    MCE Group

    Other: Motor Control Exercise · Other: Control Group

  • Experimental
    Group B

    BT Group

    Other: Balance Training · Other: Control Group

  • Experimental
    Group C

    Combined MCE \& BT Group

    Other: Motor Control Exercise · Other: Balance Training · Other: Control Group

  • Other
    Group D

    Control Group

    Other: Control Group

Interventions

  • OtherMotor Control Exercise

    Motor control exercises focusing on the activation and control of deep spinal muscles

  • OtherBalance Training

    Balance training exercises on to enhance proprioception and stability

  • OtherControl Group

    Participants received hot pack and stretching exercise

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    The pain intensity was assessed Using a numeric pain rating scale (NPRS), It's a 11 point scale, where zero indicates no pain and 10 indicates severe pain

    Time frame: 6 Weeks

  2. Functional disability

    Functional limitation was assessed by using Oswestry disability Index questionnaire Each section is scored on a 0-5 scale, 5 representing the greatest disability.

    Time frame: 6 Weeks

  3. self-reported measure of health

    It comprises 36 questions that cover eight domains of health

    Time frame: 6 Weeks

07

Study locations

2 sites
  • Integral University Hospital
    Lucknow, Uttar Pardesh, India
  • Hashim Ahmed
    Najrān, Najran 1988, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06062459
Lead sponsor
Najran University
Responsible party
Hashim Ahmed (Assistant Professor, Najran University) — Principal investigator
First posted
Oct 2, 2023
Start date
Nov 1, 2022
Primary completion
Aug 31, 2023
Completion
Sep 20, 2023
Last update
Oct 2, 2023

Study contacts

Hashim Ahmed, PhD
principal investigator · Najran University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion